Tower Research Capital LLC (Trc) Tekla Life Sciences Investors Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$13.11 - $17.02 $65 - $85	-5 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$15.35 - $19.29 $76 - $96	5 New	5 $0
Q4 2021 Feb 14, 2022	SELL	$18.5 - $21.59 $499 - $582	-27 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.27 - $22.67 $547 - $612	27 New	27 $1,000
Q1 2018 May 15, 2018	SELL	$18.92 - $21.52 $1,854 - $2,108	-98 Closed	0 $0
Q4 2017 Feb 09, 2018	SELL	$18.31 - $22.24 $15,417 - $18,726	-842 Reduced 89.57%	98 $2,000
Q3 2017 Nov 14, 2017	BUY	$20.12 - $21.88 $18,912 - $20,567	940	940 $20,000

Others Institutions Holding HQL

# of Institutions

76

Shares Held

9.23M

Call Options Held

0

Put Options Held

0

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$47.4 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.7 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.77 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.48 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.77 Million
0.14% of portfolio

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.